387 related articles for article (PubMed ID: 26038096)
1. Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2015 Oct; 54(10):993-1025. PubMed ID: 26038096
[TBL] [Abstract][Full Text] [Related]
2. Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen.
Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First MR
Transplant Proc; 2005 Mar; 37(2):867-70. PubMed ID: 15848559
[TBL] [Abstract][Full Text] [Related]
3. Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen.
Florman S; Alloway R; Kalayoglu M; Lake K; Bak T; Klein A; Klintmalm G; Busque S; Brandenhagen D; Lake J; Wisemandle K; Fitzsimmons W; First MR
Transplant Proc; 2005 Mar; 37(2):1211-3. PubMed ID: 15848672
[TBL] [Abstract][Full Text] [Related]
4. De novo kidney transplant recipients need higher doses of Advagraf compared with Prograf to get therapeutic levels.
Crespo M; Mir M; Marin M; Hurtado S; Estadella C; Gurí X; Rap O; Moral R; Puig JM; Lloveras J
Transplant Proc; 2009; 41(6):2115-7. PubMed ID: 19715848
[TBL] [Abstract][Full Text] [Related]
5. EnGraft: a multicentre, open-label, randomised, two-arm, superiority study protocol to assess bioavailability and practicability of Envarsus® versus Advagraf™ in liver transplant recipients.
Wöhl DS; James B; Götz M; Brennfleck F; Holub-Hayles I; Mutzbauer I; Baccar S; Brunner SM; Geissler EK; Schlitt HJ;
Trials; 2023 May; 24(1):325. PubMed ID: 37170284
[TBL] [Abstract][Full Text] [Related]
6. First clinical experience with the new once-daily formulation of tacrolimus.
First MR
Ther Drug Monit; 2008 Apr; 30(2):159-66. PubMed ID: 18367975
[TBL] [Abstract][Full Text] [Related]
7. Modified release tacrolimus.
First MR; Fitzsimmons WE
Yonsei Med J; 2004 Dec; 45(6):1127-31. PubMed ID: 15627307
[TBL] [Abstract][Full Text] [Related]
8. Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients.
Gaber AO; Alloway RR; Bodziak K; Kaplan B; Bunnapradist S
Transplantation; 2013 Jul; 96(2):191-7. PubMed ID: 23715050
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic modeling and development of Bayesian estimators in kidney transplant patients receiving the tacrolimus once-daily formulation.
Saint-Marcoux F; Debord J; Undre N; Rousseau A; Marquet P
Ther Drug Monit; 2010 Apr; 32(2):129-35. PubMed ID: 20110850
[TBL] [Abstract][Full Text] [Related]
10. Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients.
Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First MR
Transplantation; 2007 Jun; 83(12):1648-51. PubMed ID: 17589351
[TBL] [Abstract][Full Text] [Related]
11. Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients.
Florman S; Alloway R; Kalayoglu M; Punch J; Bak T; Melancon J; Klintmalm G; Busque S; Charlton M; Lake J; Dhadda S; Wisemandle K; Wirth M; Fitzsimmons W; Holman J; First MR
Transplantation; 2007 Jun; 83(12):1639-42. PubMed ID: 17589349
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of tacrolimus in kidney transplant recipients: twice daily versus once daily dosing.
Hardinger KL; Park JM; Schnitzler MA; Koch MJ; Miller BW; Brennan DC
Am J Transplant; 2004 Apr; 4(4):621-5. PubMed ID: 15023155
[TBL] [Abstract][Full Text] [Related]
13. Modified-release tacrolimus.
Chisholm MA; Middleton MD
Ann Pharmacother; 2006 Feb; 40(2):270-5. PubMed ID: 16449540
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.
Staatz CE; Tett SE
Clin Pharmacokinet; 2004; 43(10):623-53. PubMed ID: 15244495
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial.
Wlodarczyk Z; Squifflet JP; Ostrowski M; Rigotti P; Stefoni S; Citterio F; Vanrenterghem Y; Krämer BK; Abramowicz D; Oppenheimer F; Pietruck F; Russ G; Karpf C; Undre N
Am J Transplant; 2009 Nov; 9(11):2505-13. PubMed ID: 19681813
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus once-daily formulation: in the prophylaxis of transplant rejection in renal or liver allograft recipients.
Cross SA; Perry CM
Drugs; 2007; 67(13):1931-43. PubMed ID: 17722962
[TBL] [Abstract][Full Text] [Related]
17. Three-month experience with tacrolimus once-daily regimen in stable renal allografts.
Diez Ojea B; Alonso Alvarez M; Aguado Fernández S; Baños Gallardo M; García Melendreras S; Gómez Huertas E
Transplant Proc; 2009; 41(6):2323-5. PubMed ID: 19715908
[TBL] [Abstract][Full Text] [Related]
18. Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipients.
Heffron TG; Pescovitz MD; Florman S; Kalayoglu M; Emre S; Smallwood G; Wisemandle K; Anania C; Dhadda S; Sawamoto T; Keirns J; Fitzsimmons W; First MR
Am J Transplant; 2007 Jun; 7(6):1609-15. PubMed ID: 17511684
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic considerations relating to tacrolimus dosing in the elderly.
Staatz CE; Tett SE
Drugs Aging; 2005; 22(7):541-57. PubMed ID: 16038570
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of once-daily tacrolimus formulations in de novo liver transplant recipients: The PRETHI study.
Bilbao I; Gómez Bravo MÁ; Otero A; Lladó L; Montero JL; González Dieguez L; Graus J; Pons Miñano JA
Clin Transplant; 2023 Dec; 37(12):e15105. PubMed ID: 37615653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
